Patent · US Active

Heterodimeric immunoglobulins

US9822173B2 · kind B2 · utility

8Cited by
58References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 21, 2013
Grant dateNov 21, 2017
Priority date—
Expiry dateNov 21, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application is directed to heterodimeric antibodies and methods of use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.